UAE Bassam Abdallah, Country Division Head of Bayer Healthcare, speaks about the UAE’s economic diversification evolution, how healthcare is the leading segment in this process, and what Bayer’s strategy is to keep up with the regions changing disease portfolio. In many ways the UAE is becoming a model for other countries…
Neopharma BR Shetty, CEO of NMC Health, talks about the importance of fostering local talent—one of the biggest challenges of the region— building a company in the UAE, and where he sees the future of the company going. What did the progression and evolution of NMC Health look like, from…
UAE Ayman Sahli, CEO of Julphar Pharmaceuticals, gives his insight into the region’s growing health problems related to lifestyle changes and what this means for the company in the long run. Under your leadership, Julphar has established itself as a leading pharmaceutical company in the Middle East. What are the…
UAE Marwan Abdulaziz, Executive Director of Dubiotech, talks about the growing Life Sciences industry in the UAE, why it is important for the government to encourage biotech studies in universities, and what the major industry challenges will look like over the next several years. Dubiotech is the first free zone…
UAE Ashraf Allam, Regional Managing Director of Amgen, talks about the main challenges the company has faced, the benefit of building a company in the UAE, and the growth strategy of Amgen—past, present and future. Amgen is a relative newcomer to the region having only established is operations in 2006.…
Roche Diagnostics Moritz Hartmann, Middle East General Manager of Roche Diagnostics, gives his insight on why Roche Diagnostics made the decision to set up shop in Dubai, what the main challengers in a developing market were and will be, and why the government has been so supportive of the company’s endeavors thus…
Newbridge Pharmaceuticals Joe Henein, President & CEO of Newbridge Pharmaceuticals, talks about the evolution of the company since his joining, what makes Newbridge Pharmaceuticals a unique partner within the industry, and expounds on the many possible options for the future of the company. Newbridge Pharmaceuticals is a unique company within the Middle…
UAE Karim El-Alaoui Mustapha, Managing Diretor of Boehringer Ingelheim, MENA, talks about the company’s two-fold strategy in attracting, and maintaining, talent; what have been the key successes since it’s founding; and what the future aspirations are for the company. As the head of Boehringer Ingelheim (BI) in the Middle East, to…
Hill-Rom Jihad Hussami, EEMEA Marketing Director of Hill-Rom, talks about the company’s unique model for patient hospital care, the biggest obstacles the company has faced, and how adapting to the culture of the society has likewise led to huge successes. What have been some of Hill-Rom’s strongest activities in the Middle…
City Pharmacy Mohamed Kouta, General Manager of City Pharmacy, discusses the company’s key strengths while delving into the market’s major weaknesses and how they will affect the future of City Pharmacy. City Pharmacy has been around for quite a while now. What is one of its strong points? Dr. Adbulrahman Al Mahmeed,…
Abbvie Bassel Amer, Regional General Manager of Abbvie, discusses the company’s split in 2012, why it has been a good thing for both sides and everyone involved, including shareholders, and where he sees the Middle East market in the next five to ten years. On January 2012, Abbott split into two…
Siemens Waclaw Lukowicz, CEO of Siemens Healthcare Middle East, gives his insight into the company’s regional strategy, how both public and private healthcare is being equally addressed, and how human resources training is the biggest issue the region’s market faces. What is Siemens’ vision for healthcare in the Middle East, and…
See our Cookie Privacy Policy Here